## ALB: Albemarle Corporation - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 6.4% in lower entry zone (4.0-10.0%), top quartile (82nd pct) cross-sectional ranking. Short-term MRS_5 (3.6%) confirms momentum alignment. Strong momentum (+3.1% 5-day acceleration). Outperforming sector by 5.5%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($122.55)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Albemarle wraps up validation of lithium pilot plant in Chile**
- Source: Mining.com | 20251210T220729 | Bullish | Relevance: 99%
- Albemarle has successfully completed the validation of its direct lithium extraction (DLE) pilot plant in Chile, marking a significant step towards a future commercial facility. The pilot plant demonstrated over 94% lithium recovery and 85% water reuse, running for more than 3,000 hours. This validation allows Albemarle, a key lithium producer for EV batteries, to finalize the design for its commercial plant and proceed with its environmental review.

**2. Albemarle Corp stock hits 52-week high at $133.25 By Investing.com**
- Source: Investing.com UK | 20251210T150758 | Bullish | Relevance: 99%
- Albemarle Corp (ALB) stock reached a 52-week high of $133.25, reflecting a significant upward trend with a 27.04% increase over the past year and a 103.8% return in the last six months. This positive momentum is attributed to strong market demand and strategic company initiatives, despite InvestingPro's indication of the stock being potentially overvalued with weak gross profit margins. Recent analyst upgrades and increased price targets from firms like UBS, Baird, BMO Capital, and RBC Capital further support the bullish outlook, driven by projected growth in lithium demand.

**3. Albemarle Corp stock hits 52-week high at $133.25 By Investing.com**
- Source: Investing.com South Africa | 20251210T144251 | Bullish | Relevance: 99%
-  Albemarle Corp's stock has reached a 52-week high of $133.25, reflecting a significant upward trend with a 27.04% increase over the past year. Despite strong momentum and investor confidence leading to impressive returns, InvestingPro analysis suggests the stock might be slightly overvalued due to weak gross profit margins and negative earnings per share. The company has, however, maintained its dividend for 32 consecutive years, and recent analyst upgrades point to optimism for its future prospects in the lithium market.

**4. Albemarle Corp stock hits 52-week high at $133.25**
- Source: Investing.com | 20251210T150843 | Bullish | Relevance: 99%
-  Albemarle Corp's stock has reached a new 52-week high of $133.25, reflecting a significant upward trend with a 27.04% increase over the past year and strong momentum. Despite being potentially overvalued with weak gross profit margins and negative earnings per share, analysts have upgraded their ratings and price targets, citing optimistic forecasts for lithium market demand. The company has also maintained its dividend for 32 consecutive years.

**5. Albemarle Corp stock hits 52-week high at $133.25 By Investing.com**
- Source: Investing.com Australia | 20251210T230806 | Bullish | Relevance: 98%
-  Albemarle Corp's stock has reached a 52-week high of $133.25, showing significant upward momentum with a 27.04% increase over the past year and an impressive 103.8% return over the past six months. Despite strong investor confidence and recent analyst upgrades driven by positive lithium market forecasts, InvestingPro suggests the stock may be slightly overvalued due to weak gross profit margins and negative earnings per share.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 6, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-05 | UBS | $185 | $107 | +73% |
| 2025-12-03 | Deutsche Bank | $125 | $110 | +14% |
| 2025-12-02 | Baird | $113 | $81 | +40% |
| 2025-11-19 | BMO Capital | $136 | $125 | +9% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-05 | UBS | up | Buy |
| 2025-12-03 | Deutsche Bank | main | Hold |
| 2025-12-02 | Baird | up | Neutral |
| 2025-11-19 | BMO Capital | main | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 3 ($0.03M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital World Invest: 7.0% (+0.2%)
- Blackrock Inc.: 7.0% (-0.1%)
- State Street Corpora: 4.8% (-15.4%)
- Franklin Resources, : 2.8% (-42.8%)

### Key Risks

1. Volume divergence: price rising (+3.1% MRS) on declining volume (60% of avg) suggests distribution.
2. Valuation stretched: PEG 4.5x requires aggressive growth execution.
3. Elevated short interest (12.5%): bears positioning against stock.

### Catalysts

- Analyst target momentum: 6 raises (avg +30%) could attract flows.
- Momentum building: MRS_20 improving +3.1% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 4.55 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (6 raises, avg +30%). Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $15.8B |
| Beta | 1.43 |
| 52W Range | $49.43 - $135.13 |
| Short Interest | 12.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.55 |
| Forward P/E | 187.3 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 strengthening from 3.3% to 6.4% (+3.1% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 82nd percentile. MRS_5 at 3.6% confirms short-term momentum alignment. AM_20 at 8.7% shows strong absolute momentum above own 20MA. Outperforming sector by 5.5pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 6.39% (CS: 83) | Strong |
| RSI_14 | 68.3 | Neutral |
| MACD Histogram | 0.06 | Bullish |
| vs SMA20 | 1.087x | Above |
| vs SMA50 | 1.259x | Above |
| vs SMA200 | 1.707x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $134.59
- **Stop Loss:** $122.55 (8.9% risk)
- **Target:** $152.65 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 114
- **Position Value:** $15,343.26
- **Portfolio %:** 15.34%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $-0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.88 | $-0.19 | +78.3% |
| 2025Q2 | $-0.81 | $0.11 | +113.5% |
| 2025Q1 | $-0.68 | $-0.18 | +73.5% |
| 2024Q4 | $-0.67 | $-1.09 | -63.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*